Impact of melatonin on immunity: a review

[1] Ivanova TN, Iuvone PM. Melatonin synthesis in retina: circadian regulation of arylalkylamine N-acetyltransferase activity in cultured photoreceptor cells of embryonic chicken retina. Brain Res 2003; 973: 56–63 http://dx.doi.org/10.1016/S0006-8993(03)02540-X10.1016/S0006-8993(03)02540-XSearch in Google Scholar

[2] do Carmo Buonfiglio D, Peliciari-Garcia RA, do Amaral FG et al. Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic wistar rats. Invest Ophthalml Vis Sci 2011; 52: 7416–7422 http://dx.doi.org/10.1167/iovs.10-675610.1167/iovs.10-6756Search in Google Scholar PubMed

[3] Konturek PC, Brzozowski T, Konturek SJ. Gut clock: implication of circadian rhythms in the gastrointestinal tract. J Physiol Pharmacol 2011; 62: 139–150 Search in Google Scholar

[4] Hasan S, Santhi N, Lazar AS et al. Assessment of circadian rhythms in humans: comparison of realtime fibroblast reporter imaging with plasma melatonin. Faseb J 2012; 26: 2414–2423 DOI: 10.1096/fj.11-201699 http://dx.doi.org/10.1096/fj.11-20169910.1096/fj.11-201699Search in Google Scholar PubMed PubMed Central

[5] Smulevich AB, Dubnitskaya EB. A dimensional rhythmological model of depression. Z Nevrol Psikhiatrii Im S S Korsakova 2010; 110: 4–10 Search in Google Scholar

[6] Hur SP, Takeuchi Y, Itoh H et al. Fish sleeping under sandy bottom: Interplay of melatonin and clock genes. Gen Comp Endocrinol 2012; 177: 37–45 DOI: 10.1016/j.ygcen.2012.01.007 http://dx.doi.org/10.1016/j.ygcen.2012.01.00710.1016/j.ygcen.2012.01.007Search in Google Scholar PubMed

[7] Barrett P, Bolborea M. Molecular pathways involved in seasonal body weight and reproductive responses governed by melatonin. J Pineal Res 2012; 52: 376–388 DOI: 10.1111/j.1600-079X.2011.00963.x http://dx.doi.org/10.1111/j.1600-079X.2011.00963.x10.1111/j.1600-079X.2011.00963.xSearch in Google Scholar PubMed

[8] Deregnaucourt S, Saar S, Gahr M. Melatonin affects the temporal pattern of vocal signatures in birds. J Pineal Res 2012; 53: 245–258 DOI: 10.1111/j.1600-079X.2012.00993.x http://dx.doi.org/10.1111/j.1600-079X.2012.00993.x10.1111/j.1600-079X.2012.00993.xSearch in Google Scholar PubMed

[9] Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006; 60: 97–108 DOI: 10.1016/j.biopha.2006.01.002 http://dx.doi.org/10.1016/j.biopha.2006.01.00210.1016/j.biopha.2006.01.002Search in Google Scholar PubMed

[10] Jaworek J, Szklarczyk J, Jaworek AK et al. Protective effect of melatonin on acute pancreatitis. Int J Inflam 2012; 2012: 173675 10.1155/2012/173675Search in Google Scholar PubMed PubMed Central

[11] Pohanka M. Alzheimer’s disease and related neurodegenerative disorders: implication and counteracting of melatonin. Journal of Applied Biomedicine 2011; 9: 185–196 DOI: DOI 10.2478/v10136-011-0003-6 10.2478/v10136-011-0003-6Search in Google Scholar

[12] Alonso-Vale MI, Andreotti S, Mukai PY et al. Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes. J Pineal Res 2008; 45: 422–429 http://dx.doi.org/10.1111/j.1600-079X.2008.00610.x10.1111/j.1600-079X.2008.00610.xSearch in Google Scholar PubMed

[13] Gumenyuk V, Roth T, Drake CL. Circadian phase, sleepiness, and light exposure assessment in night workers with and without shift work disorder. Chronobiol Int 2012; 29: 928–936 http://dx.doi.org/10.3109/07420528.2012.69935610.3109/07420528.2012.699356Search in Google Scholar PubMed

[14] Bhatti P, Mirick DK, Davis S. Invited commentary: shift work and cancer. Am J Epidemiol 2012; 176: 760–763 http://dx.doi.org/10.1093/aje/kws31110.1093/aje/kws311Search in Google Scholar PubMed

[15] Rodriguez-Naranjo MI, Moya ML, Cantos-Villar E et al. Comparative evaluation of the antioxidant activity of melatonin and related indoles. J Food Compos Anal 2012; 28: 16–22 DOI: 10.1016/j.jfca.2012.07.001 http://dx.doi.org/10.1016/j.jfca.2012.07.00110.1016/j.jfca.2012.07.001Search in Google Scholar

[16] Ozturk G, Akbulut KG, Guney S et al. Age-related changes in the rat brain mitochondrial antioxidative enzyme ratios: Modulation by melatonin. Exp Gerontol 2012; 47: 706–711 DOI: 10.1016/j.exger.2012.06.011 http://dx.doi.org/10.1016/j.exger.2012.06.01110.1016/j.exger.2012.06.011Search in Google Scholar PubMed

[17] Ozturk G, Coskun S, Erbas D et al. The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels. Jpn J Physiol 2000; 50: 149–153 DOI: 10.2170/jjphysiol.50.149 http://dx.doi.org/10.2170/jjphysiol.50.14910.2170/jjphysiol.50.149Search in Google Scholar PubMed

[18] Cutando A, Aneiros-Fernandez J, Lopez-Valverde A et al. A new perspective in Oral health: potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR/ROR in the oral cavity. Arch Oral Biol 2011; 56: 944–950 http://dx.doi.org/10.1016/j.archoralbio.2011.03.00410.1016/j.archoralbio.2011.03.004Search in Google Scholar PubMed

[19] Dubocovich ML. Melatonin receptors: Role on sleep and circadian rhythm regulation. Sleep Med 2007; 8: S34–S42 DOI: 10.1016/j.sleep.2007.10.007 http://dx.doi.org/10.1016/j.sleep.2007.10.00710.1016/j.sleep.2007.10.007Search in Google Scholar PubMed

[20] Mor M, Rivara S, Pala D et al. Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists. Expert Opin Ther Pat 2010; 20: 1059–1077 http://dx.doi.org/10.1517/13543776.2010.49645510.1517/13543776.2010.496455Search in Google Scholar PubMed

[21] Spadoni G, Bedini A, Rivara S et al. Melatonin receptor agonists: new options for insomnia and depression treatment. CNS Neurosci Ther 2011; 17: 733–741 http://dx.doi.org/10.1111/j.1755-5949.2010.00197.x10.1111/j.1755-5949.2010.00197.xSearch in Google Scholar PubMed PubMed Central

[22] Vella F, Gilles FA, Delagrange P et al. NRH: quinone reductase 2: An enzyme of surprises and mysteries. Biochem Pharmacol 2005; 71: 1–12 DOI: 10.1016/j.bcp.2005.09.019 http://dx.doi.org/10.1016/j.bcp.2005.09.01910.1016/j.bcp.2005.09.019Search in Google Scholar PubMed

[23] Tan DX, Manchester LC, Terron MP et al. Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance. J Pineal Res 2007; 43: 317–320 DOI: 10.1111/j.1600-079X.2007.00513.x http://dx.doi.org/10.1111/j.1600-079X.2007.00513.x10.1111/j.1600-079X.2007.00513.xSearch in Google Scholar PubMed

[24] Boutin JA, Marcheteau E, Henning P et al. MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate. J Pineal Res 2008; 45: 524–531 http://dx.doi.org/10.1111/j.1600-079X.2008.00631.x10.1111/j.1600-079X.2008.00631.xSearch in Google Scholar PubMed

[25] Boutin JA, Saunier C, Guenin SP et al. Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis. Arch Biochem Biophys 2008; 477: 12–19 DOI: 10.1016/j. abb.2008.04.040 http://dx.doi.org/10.1016/j.abb.2008.04.04010.1016/j.abb.2008.04.040Search in Google Scholar PubMed

[26] Reybier K, Perio P, Ferry G et al. Insights into the redox cycle of human quinone reductase 2. Free Radic Res 2011; 45: 1184–1195 DOI: 10.3109/10715762.2011.605788 http://dx.doi.org/10.3109/10715762.2011.60578810.3109/10715762.2011.605788Search in Google Scholar PubMed

[27] Carbajo-Pescador S, Martin-Renedo J, Garcia-Palomo A et al. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells. J Pineal Res 2009; 47: 330–338 DOI: 10.1111/j.1600-079X.2009.00719.x http://dx.doi.org/10.1111/j.1600-079X.2009.00719.x10.1111/j.1600-079X.2009.00719.xSearch in Google Scholar PubMed

[28] Stehlin-Gaon C, Willmann D, Zeyer D et al. Alltrans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat Struct Biol 2003; 10: 820–825 DOI: 10.1038/nsb979 http://dx.doi.org/10.1038/nsb97910.1038/nsb979Search in Google Scholar PubMed

[29] Lardone PJ, Guerrero JM, Fernandez-Santos JM et al. Melatonin synthesized by T lymphocytes as a ligand of the retinoic acid-related orphan receptor. J Pineal Res 2011; 51: 454–462 DOI: 10.1111/j.1600-079X.2011.00909.x http://dx.doi.org/10.1111/j.1600-079X.2011.00909.x10.1111/j.1600-079X.2011.00909.xSearch in Google Scholar PubMed

[30] Missbach M, Jagher B, Sigg I et al. Thiazolidine diones, specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor alpha with potent antiarthritic activity. Journal of Biological Chemistry 1996; 271: 13515–13522 http://dx.doi.org/10.1074/jbc.271.23.1351510.1074/jbc.271.23.13515Search in Google Scholar PubMed

[31] Agez L, Laurent V, Pevet P et al. Melatonin affects nuclear orphan receptors mRNA in the rat suprachiasmatic nuclei. Neuroscience 2007; 144: 522–530 DOI: 10.1016/j.neuroscience.2006.09.030 http://dx.doi.org/10.1016/j.neuroscience.2006.09.03010.1016/j.neuroscience.2006.09.030Search in Google Scholar PubMed

[32] Kiefer TL, Lai L, Yuan L et al. Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins. J Pineal Res 2005; 38: 231–239 DOI: 10.1111/j.1600-079X.2004.00198.x http://dx.doi.org/10.1111/j.1600-079X.2004.00198.x10.1111/j.1600-079X.2004.00198.xSearch in Google Scholar PubMed

[33] Pohanka M. Antioxidants countermeasures against sulfur mustard. Mini-Rev Med Chem 2012; 12: 742–748 http://dx.doi.org/10.2174/13895571280126478310.2174/138955712801264783Search in Google Scholar

[34] Tamura EK, Cecon E, Monteiro AWA et al. Melatonin inhibits LPS-induced NO production in rat endothelial cells. J Pineal Res 2009; 46: 268–274 DOI: 10.1111/j.1600-079X.2008.00657.x http://dx.doi.org/10.1111/j.1600-079X.2008.00657.x10.1111/j.1600-079X.2008.00657.xSearch in Google Scholar

[35] Camacho ME, Carrion MD, Lopez-Cara LC et al. Melatonin synthetic analogs as nitric oxide synthase inhibitors. Mini-Rev Med Chem 2012; 12: 600–617 http://dx.doi.org/10.2174/13895571280062667410.2174/138955712800626674Search in Google Scholar

[36] Koh PO. Melatonin regulates nitric oxide synthase expression in ischemic brain injury. J Vet Med Sci 2008; 70: 747–750 DOI: 10.1292/jvms.70.747 http://dx.doi.org/10.1292/jvms.70.74710.1292/jvms.70.747Search in Google Scholar

[37] Marczynski TJ, Yamaguchi N, Ling GM et al. Sleep induced by the administration of melatonin (5-methoxynacetyltryptamine) to the hypothalamus in unrestrained cats. Experimentia 1964; 20: 435–437 http://dx.doi.org/10.1007/BF0215213410.1007/BF02152134Search in Google Scholar

[38] Pieri C, Marra M, Moroni F et al. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sciences 1994; 55: 271–276 http://dx.doi.org/10.1016/0024-3205(94)00666-010.1016/0024-3205(94)00666-0Search in Google Scholar

[39] Pieri C, Moroni F, Marra M et al. Melatonin is an efficient antioxidant. Arch Gerontol Geriatr 1995; 20: 159–165 http://dx.doi.org/10.1016/0167-4943(94)00593-V10.1016/0167-4943(94)00593-VSearch in Google Scholar

[40] Chen HY, Chen TY, Lee MY et al. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res 2006; 41: 175–182 http://dx.doi.org/10.1111/j.1600-079X.2006.00351.x10.1111/j.1600-079X.2006.00351.xSearch in Google Scholar PubMed

[41] Shirazi A, Ghobadi G, Ghazi-Khansari M. A radiobiological review on melatonin: a novel radioprotector. J Radiat Res 2007; 48: 263–272 http://dx.doi.org/10.1269/jrr.0607010.1269/jrr.06070Search in Google Scholar PubMed

[42] Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28–42 http://dx.doi.org/10.1111/j.1600-079X.2006.00407.x10.1111/j.1600-079X.2006.00407.xSearch in Google Scholar PubMed

[43] Fischer TW, Kleszczynski K, Hardkop LH et al. Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVRinduced depletion, and protects against the formation of DNA damage (8-hydroxy-2′-deoxyguanosine) in ex vivo human skin. J Pineal Res 2012; doi: 10.1111/jpi.12018 10.1111/jpi.12018Search in Google Scholar PubMed

[44] Shagirtha K, Muthumani M, Prabu SM. Melatonin abrogates cadmium induced oxidative stress related neurotoxicity in rats. Eur Rev Med Pharmacol Sci 2011; 15: 1039–1050 Search in Google Scholar

[45] Korkmaz GG, Uzun H, Cakatay U et al. Melatonin ameliorates oxidative damage in hyperglycemiainduced liver injury. Clinical and investigative medicine Medecine clinique et experimentale 2012; 35: E370 10.25011/cim.v35i6.19209Search in Google Scholar PubMed

[46] Ali SA, Aly HF, Faddah LM et al. Dietary supplementation of some antioxidants against hypoxia. World J Gastroenterol 2012; 18: 6379–6386 http://dx.doi.org/10.3748/wjg.v18.i44.637910.3748/wjg.v18.i44.6379Search in Google Scholar PubMed PubMed Central

[47] Karaoz E, Gultekin F, Akdogan M et al. Protective role of melatonin and a combination of vitamin C and vitamin E on lung toxicity induced by chlorpyrifosethyl in rats. Exp Toxicol Pathol 2002; 54: 97–108 http://dx.doi.org/10.1078/0940-2993-0023610.1078/0940-2993-00236Search in Google Scholar PubMed

[48] Yellon SM, Tran LT. Photoperiod, reproduction, and immunity in select strains of inbred mice. J Biol Rhythms 2002; 17: 65–75 http://dx.doi.org/10.1177/07487300212900234810.1177/074873002129002348Search in Google Scholar PubMed

[49] Zhang Z, Inserra PF, Liang B et al. Melatonin, immune modulation and aging. Autoimmunity 1997; 26: 43–53 http://dx.doi.org/10.3109/0891693970900954910.3109/08916939709009549Search in Google Scholar PubMed

[50] Santello FH, Frare EO, dos Santos CD et al. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi. J Pineal Res 2008; 45: 291–296 http://dx.doi.org/10.1111/j.1600-079X.2008.00589.x10.1111/j.1600-079X.2008.00589.xSearch in Google Scholar PubMed

[51] Brazao V, Del Vecchio Filipin M, Santello FH et al. Melatonin and zinc treatment: distinctive modulation of cytokine production in chronic experimental Trypanosoma cruzi infection. Cytokine 2011; 56: 627–632 http://dx.doi.org/10.1016/j.cyto.2011.08.03710.1016/j.cyto.2011.08.037Search in Google Scholar PubMed

[52] Xia MZ, Liang YL, Wang H et al. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells. J Pineal Res 2012; 53: 325–334 http://dx.doi.org/10.1111/j.1600-079X.2012.01002.x10.1111/j.1600-079X.2012.01002.xSearch in Google Scholar PubMed

[53] Lee YD, Kim JY, Lee KH et al. Melatonin attenuates lipopolysaccharide-induced acute lung inflammation in sleep-deprived mice. J Pineal Res 2009; 46: 53–57 http://dx.doi.org/10.1111/j.1600-079X.2008.00621.x10.1111/j.1600-079X.2008.00621.xSearch in Google Scholar PubMed

[54] Sinanoglu O, Sezgin G, Ozturk G et al. Melatonin with 1,25-Dihydroxyvitamin D3 Protects against Apoptotic Ischemia-Reperfusion Injury in the Rat Kidney. Ren Fail 2012; 34: 1021–1026 DOI: 10.3109/0886022x.2012.700887 http://dx.doi.org/10.3109/0886022X.2012.70088710.3109/0886022X.2012.700887Search in Google Scholar PubMed

[55] Cotto-Rios XM, Bekes M, Chapman J et al. Cell Rep. Deubiquitinases as a Signaling Target of Oxidative Stress 2012; doi: 10.1016/j.celrep.2012.11.011 10.1016/j.celrep.2012.11.011Search in Google Scholar PubMed PubMed Central

[56] Kodama R, Kato M, Furuta S et al. ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence. Genes Cells 2012; doi: 10.1111/gtc.12015 10.1111/gtc.12015Search in Google Scholar PubMed

[57] Liu RM, Choi J, Wu JH et al. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem 2010; 285: 16239–16247 http://dx.doi.org/10.1074/jbc.M110.11173210.1074/jbc.M110.111732Search in Google Scholar PubMed PubMed Central

[58] Cutando A, Lopez-Valverde A, Arias-Santiago S et al. Role of melatonin in cancer treatment. Anticancer Res 2012; 32: 2747–2753 Search in Google Scholar

[59] Brigo F, Del Felice A. Melatonin as add-on treatment for epilepsy. Cochrane Database Syst Rev 2012; 6: CD006967 10.1002/14651858.CD006967.pub2Search in Google Scholar PubMed

[60] Boga JA, Coto-Montes A, Rosales-Corral SA et al. Beneficial actions of melatonin in the management of viral infections: a new use for this ”molecular handyman”? Rev Med Virol 2012; 22: 323–338 DOI: 10.1002/rmv.1714 http://dx.doi.org/10.1002/rmv.171410.1002/rmv.1714Search in Google Scholar PubMed PubMed Central

[61] Pohanka M. Acetylcholinesterase inhibitors: a patent review (2008 — present). Expert Opin Ther Pat 2012; 22: 871–886 DOI: 10.1517/13543776.2012.701620 http://dx.doi.org/10.1517/13543776.2012.70162010.1517/13543776.2012.701620Search in Google Scholar PubMed

[62] Pohanka M. Cholinesterases, a target of pharmacology and toxicology. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2011; 155: 219–229 DOI: 10.5507/bp.2011.036 http://dx.doi.org/10.5507/bp.2011.03610.5507/bp.2011.036Search in Google Scholar PubMed

[63] Martino M, Rocchi G, Escelsior A et al. Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance. Curr Neuropharmacol 2012; 10: 97–123 http://dx.doi.org/10.2174/15701591280060454210.2174/157015912800604542Search in Google Scholar PubMed PubMed Central

[64] Islam MA, Uddin MJ, Tholen E et al. Age-related changes in phagocytic activity and production of pro-inflammatory cytokines by lipopolysaccharide stimulated porcine alveolar macrophages. Cytokine 2012; 60: 707–717 DOI: 10.1016/j.cyto.2012.08.011 http://dx.doi.org/10.1016/j.cyto.2012.08.01110.1016/j.cyto.2012.08.011Search in Google Scholar PubMed

[65] van Besouw NM, Verjans G, Zuijderwijk JM et al. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients. J Med Virol 2012; 84: 2018–2025 DOI: 10.1002/jmv.23427 http://dx.doi.org/10.1002/jmv.2342710.1002/jmv.23427Search in Google Scholar PubMed

[66] Rybka J, Kedziora-Kornatowska K, Kedziora J et al. Immunosenescence and late life depression. Centr Eur J Immunol 2009; 34: 271–275 Search in Google Scholar

[67] Manikonda PK, Jagota A. Melatonin administration differentially affects age-induced alterations in daily rhythms of lipid peroxidation and antioxidant enzymes in male rat liver. Biogerontology 2012; 13: 511–524 DOI: 10.1007/s10522-012-9396-1 http://dx.doi.org/10.1007/s10522-012-9396-110.1007/s10522-012-9396-1Search in Google Scholar PubMed

[68] Rastmanesh R. Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity. Med Hypotheses 2011; 76: 79–85 DOI: 10.1016/j.mehy.2010.08.036 http://dx.doi.org/10.1016/j.mehy.2010.08.03610.1016/j.mehy.2010.08.036Search in Google Scholar PubMed

[69] Mozaffari S, Abdollahi M. Melatonin, a Promising Supplement in Inflammatory Bowel Disease: A Comprehensive Review of Evidences. Curr Pharm Design 2011; 17: 4372–4378 http://dx.doi.org/10.2174/13816121179899935710.2174/138161211798999357Search in Google Scholar PubMed

[70] Huai JP, Sun XC, Chen MJ et al. Melatonin attenuates acute pancreatitis-associated lung injury in rats by modulating interleukin 22. World Journal of Gastroenterology 2012; 18: 5122–5128 DOI: 10.3748/wjg.v18.i36.5122 http://dx.doi.org/10.3748/wjg.v18.i36.512210.3748/wjg.v18.i36.5122Search in Google Scholar PubMed PubMed Central

[71] Srinivasan V, Spence DW, Trakht I et al. Immunomodulation by melatonin: Its significance for seasonally occurring diseases. Neuroimmunomodulation 2008; 15: 93–101 DOI: 10.1159/000148191 http://dx.doi.org/10.1159/00014819110.1159/000148191Search in Google Scholar PubMed

[72] Lissoni P. Is there a role for melatonin in supportive care? Support Care Cancer 2002; 10: 110–116 DOI: 10.1007/s005200100281 http://dx.doi.org/10.1007/s00520010028110.1007/s005200100281Search in Google Scholar PubMed

[73] Bekyarova G, Bratchkova Y, Tancheva S et al. Effective melatonin protection of burn-induced hepatic disorders in rats. Cent Eur J Med 2012; 7: 533–538 DOI: 10.2478/s11536-012-0006-z http://dx.doi.org/10.2478/s11536-012-0006-z10.2478/s11536-012-0006-zSearch in Google Scholar

[74] Bekyarova G, Apostolova M, Kotzev I. Melatonin protection against burn-induced hepatic injury by down-regulation of nuclear factor kappa B activation Int J Immunopathol Pharmacol 2012; 25: 591–596 10.1177/039463201202500305Search in Google Scholar PubMed

[75] Terry PD, Villinger F, Bubenik GA et al. Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research. Inflamm Bowel Dis 2009; 15: 134–140 DOI: 10.1002/ibd.20527 http://dx.doi.org/10.1002/ibd.2052710.1002/ibd.20527Search in Google Scholar PubMed